Problems in the classification of CMML - Dysplastic versus proliferative type

Leukemia Research

Volumn 22, Issue 10, 1998, Pages 871-878

  Germing, Ulrich ^a   Gattermann, Norbert ^a   Minning, Horst ^a   Heyll, Axel ^a   Aul, Carlo ^a  

^a Oncol Clin Immunol Heinrich H   (Germany)

Author keywords

Classification; CMML; Myelodysplastic syndromes; Myeloproliferative disorders; Prognosis

Indexed keywords

LACTATE DEHYDROGENASE; THYMIDINE KINASE;

ADULT; AGED; ARTICLE; BLAST CELL; BONE MARROW CELL; CELL STRUCTURE; CHRONIC MYELOMONOCYTIC LEUKEMIA; DISEASE CLASSIFICATION; ENZYME BLOOD LEVEL; FEMALE; FOLLOW UP; GRANULOPOIESIS; HUMAN; HUMAN CELL; LACTATE DEHYDROGENASE BLOOD LEVEL; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MEGAKARYOPOIESIS; MULTIVARIATE ANALYSIS; MYELODYSPLASTIC SYNDROME; MYELOPROLIFERATIVE DISORDER; NEUTROPHIL; PRIORITY JOURNAL; PROGNOSIS; SCORING SYSTEM; SEX RATIO; SPLENOMEGALY; SURVIVAL RATE; SURVIVAL TIME;

ADULT; AGED; AGED, 80 AND OVER; CELL DIVISION; ERYTHROPOIESIS; FEMALE; HUMANS; LEUKEMIA, MYELOMONOCYTIC, CHRONIC; MALE; MIDDLE AGED; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 0032190687     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(97)00192-6     Document Type: Article

References (24)

1. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C Proposals for the classification of the myelodysplastic syndromes. Br J Haematol. 51:1982;189.
2. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C, Cox C The chronic myeloid leukemias: guidelines for distinguishing chronic granulocytic, atypical chronic myeloid, and chronic myelomonocytic leukaemia. Proposals by the French-American-British Cooperative leukaemia group. Br J Haematol. 87:1994;746.
3. Kaplan EL, Meier P Nonparametric estimation from incomplete observations. J Am Statist Assoc. 53:1958;457.
4. Snedecar GW, Cochran WB. Statistical Methods. 6th ed. Ames: Iowa State University Press, 1967.
5. Cox DR Regression models and life-tables. J R Statist Soc. 34:1972;187.
6. Toyama K, Ohyashiki K, Yoshida Y, Abe T, Asano S, Hirai H, Hirashima K, Hotta T, Kuramato A, Kuriya S, Miyazaki T, Kakishita E, Mizogushi H, Okada M, Shirakawa S, Takaku F, Tomonaga M, Uchino H, Yasanuga K, Nomura T Clinical implication of chromosomal abnormalities in 401 patients with myelodysplastic syndromes: a multicentric study in Japan. Leukemia. 7:1993;499.
7. Groupe Francais de Cytogenetique Hematologique Chronic myelomonocytic leukaemia: single entity or heterogeneous disorder? A prospective multicenter study of 100 patients. Cancer Genet Cytogene. 55:1991;57.
8. Aul C, Gattermann N, Germing U, Südhoff T, Hollmig KA, Heyll A Fatal hyperleukocytic syndrome in a patient with chronic myelomonocytic leukemia. Leuk Res. 21:1997;249.
9. Aul C, Gattermann N, Heyll A, Germing U, Derigs G, Schneider W Primary myelodysplastic syndromes (MDS): analysis of prognostic factors in 235 patients and proposals for an improved scoring system. Leukemia. 6:1992;52.
10. Worsley A, Oscier DG, Stevens J, Darlow S, Figes A, Mufti GJ, Hamblin TJ Prognostic features of chronic myelomonocytic leukaemia: a modified Bournemouth score gives the best prediction of survival. Br J Haematol. 68:1988;17.
11. Sanz GF, Sanz MA, Vallespi T, Canizo MC, Torrabadella M, Garcia S, Irriguible D, San Miguel JF Two regression models and a scoring system for predicting survival and planning treatment in myelodysplastic syndromes: a multivariate analysis of prognostic factors in 370 patients. Blood. 74:1989;395.
12. Ribera JM, Cervantes F, Rozman C A multivariate analysis of prognostic factors in chronic myelomonocytic leukaemia according to the FAB criteria. Br J Haematol. 65:1987;307.
13. Kerkhofs H, Hermanns J, Haak HL, Leeksma HW Utility of the FAB classification for myelodysplastic syndrome: Investigation of prognostic factors in 237 cases. Br J Haematol. 65:1987;73.
14. Fenaux P, Jouet JP, Zandecki M, Lai JL, Simon M, Pollet JP, Bauters F Chronic and subacute myelomonocytic leukaemia in the adult: a report of 60 cases with special reference to prognostic factors. Br J Haematol. 65:1987;101.
15. Stark AN, Thorogod J, Head C, Roberts BE, Scott CS Prognostic factors and survival in chronic myelomonocytic leukaemia (CMML). Br J Cancer. 56:1987;59.
16. del Canizo MC, Sanz G, San Miguel JF, Vallespie T, Irriguible D, Torrabadella M, Sanz MA Chronic myelomonocytic leukemia - clinicobiological characteristics: A multivariate analysis in a series of 70 cases. Eur J Haematol. 42:1989;466.
17. Storniolo AM, Moloney WC, Rosenthal DS, Cox C, Bennett JM Chronic myelomonocytic leukemia. Leukemia. 4:1990;766.
18. Solal-Celigny P, Desaint B, Herrera A, Chastang C, Amar M, Vroclans M, Brousse N, Mancilla F, Renoux M, Bernard JF, Boivin P Chronic myelomoncytic leukemia according to FAB classification: analysis of 35 cases. Blood. 63:1984;634.
19. Aul C, Gattermann N, Germing U, Runde V, Heyll A, Schneider W Risk assessment in primary myelodysplastic syndromes: validation of the Düsseldorf score. Leukemia. 8:1994;1906.
20. Oguma S, Yoshida Y, Uduino H, Mackawa T, Nomura T, Mizogudi H Clinical characteristics of Japanese patients with primary myelodysplastic syndromes: a cooperative study based on 838 cases. Leuk Res. 19:1995;219.
21. Michaux JL, Martiat P Chronic myelomonocytic leukaemia (CMML). A myelodysplastic or myeloproliferative syndrome? Leuk Lymphoma. 9:1993;35.
22. Cervera J, Sanz GF, Vallespie T, del Canizo MC, Irriguible D, Lopez F, Sanchez-Morata C, Larrea L, Blanco A, Benlloch L, Julia A, San Miguel JF, Sanz MA Does WBC really define two different subtypes of chronic myelomonocytic leukemia (CMML)? Analysis of a series of 119 patients. Leuk Res. 21(1):1997;27.
23. Vallespie T, Blanco A, Sanchez-Morata C, Sanz GF Proliferative chronic myelomonocytic leukemia (P-CMML) emerging after splenectomy in two patients with dysplastic CMML (D-CMML). Leuk Res. 21(1):1997;29.
24. Greenberg P, Cox C, LeBeau MM, Fenaux P, Morel P, Sanz G, Sanz M, Vallespi T, Hamblin T, Oscier D, Ohyashiki K, Toyama K, Aul C, Mufti G, Bennett J. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood, 1997;6:2079.